Dr. Robert Green, MD

• Neurology

• Genetics

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Phoenix / Northern California Campus

  Medical School, 1980

• Disclosure of personalized rheumatoid arthritis risk using genetics, biomarkers, and lifestyle factors to motivate health behavior improvements: A randomized controlled trial, 2018-04-16

• In the Early Postpartum Period, Parents are Interested in Newborn Genomic Testing, 2014-12-04

• Improved Provider Preparedness through an Eight-Part Genetics and Genomic Education Program, 2021-11-30

• Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative, 2015-04-04

• Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing, 2019-02-28

• Discordant Results Between Conventional Newborn Screening and Genomic Sequencing in the BabySeq Project, 2021-03-26

• Successful Recruitment of Centenarians for Post-Mortem Brain Donation: Results from the Georgia Centenarian Study, 2013-07-26

• A Randomized Controlled Trial of Disclosing Genetic Risk Information for Alzheimer's Disease via Telephone, 2017-07-20

• Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium, 2013-10-24

• The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable, 2016-02-21

• A Whole Genome Approach for Discovering the Genetic Basis of Blood Group Antigens: Independent Confirmation for P1 and Xga, 2018-12-28

• Communicating Genetic Risk Information for Common Disorders in the Era of Genomic Medicine, 2013-05-14

• Airmen and Healthcare Providers' attitudes toward the use of genomic sequencing in the US Air Force: Findings from the MilSeq Project, 2020-08-18

• Diet and exercise changes following direct-to-consumer personal genomic testing, 2017-05-02

• Incorporating a Genetic Risk Score into Coronary Heart Disease Risk Estimates: Effect on LDL Cholesterol Levels (the MIGENES Clinical Trial), 2016-02-25

• A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health, 2018-08-02

• Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants, 2015-05-12

• A Randomized Non-inferiority Trial of Condensed Protocols for Genetic Risk Disclosure of Alzheimer's Disease, 2014-12-09

• Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations, 2015-06-05

• Effectiveness of a condensed protocol for disclosingAPOEgenotype and providing risk education for Alzheimer disease, 2012-04-12

• The price of whole-genome sequencing may be decreasing, but who will be sequenced?, 2017-05-23

• Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study, 2021-08-18

• Integration of bioinformatics and imaging informatics for identifying rarePSEN1variants in Alzheimer's disease, 2016-08-12

• Assembly of 809 whole mitochondrial genomes with clinical, imaging, and fluid biomarker phenotyping, 2018-01-05

• Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014, 2015-11-17

• An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discovery, 2018-08-13

• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, 2016-11-17

• Management of Incidental Findings in Clinical Genomic Sequencing, 2013-07-25

• Disclosing Pleiotropic Effects during Genetic Risk Assessment for Alzheimer's Disease: A Randomized, Controlled Trial, 2016-01-26

• Preferences for the return of individual results from research on pediatric biobank samples, 2016-09-13

• Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project, 2019-03-17

• Common folate gene variant,MTHFRC677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment, 2012-10-04

• Adopting Genetics: Motivations and Outcomes of Personal Genomic Testing in Adult Adoptees, 2016-01-28

• Precision Population Medicine in Primary Care: The Sanford Chip Experience, 2021-03-12

• Primary care providers' responses to unsolicited Lynch syndrome secondary findings of varying clinical significance, 2021-06-10

• Patient understanding of, satisfaction with, and perceived utility of whole genome sequencing: Findings from the MedSeq Project, 2018-01-04

• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, 2011-11-02

• Prescription medication changes following direct-to-consumer personal genomic testing: Findings from the Impact of Personal Genomics (PGen) Study, 2016-09-22

• Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study, 2021-11-03

• A randomized trial of the clinical utility of genetic testing for obesity: Design and implementation considerations, 2013-11-11

• Participant and study decliners' perspectives about the risks of participating in a clinical trial of whole genome sequencing, 2016-02-28

• A randomized trial examining the impact of communicating genetic and lifestyle risks for obesity, 2016-08-10

• Challenging the Current Recommendations for Carrier Testing in Children, 2019-03-17

• ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing, 2013-06-20

• Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients, 2021-08-24

• Reporting Genomic Sequencing Results to Ordering Clinicians Incidental, but Not Exceptional, 2013-07-24

• Psychological Outcomes Related to Exome and Genome Sequencing Result Disclosure: A Meta-Analysis of Seven Clinical Sequencing Exploratory Research (CSER) Consortium Studies, 2019-06-13

• Perspectives of Rare Disease Experts on Newborn Genome Sequencing Perspectives of Rare Disease Experts on Newborn Genome Sequencing, 2023-05-08

• Reconciling newborn screening and a novel splice variant inBTDassociated with partial biotinidase deficiency: a BabySeq Project case report BabySeq BTD case report, 2018-08-01

• The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors, 2011-11-04

• An eMERGE Clinical Center at Partners Personalized Medicine, 2016-01-20

• Managing Incidental Findings and Research Results in Genomic Research Involving Biobanks & Archived Datasets, 2013-02-28

• The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease, 2017-11-27

• Genomic medicine in the military, 2016-01-13

• APOEandBCHEas modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study, 2013-02-19

• Development and Validation of a Comprehensive Genomics Knowledge Scale, 2021-05-31

• Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials, 2017-03-22

• A Taxonomy of Medical Uncertainties in Clinical Genome Sequencing, 2017-01-19

• Common genetic variants influence human subcortical brain structures, 2015-01-21

• Variations in predicted risks in personal genome testing for common complex diseases, 2013-06-27

• Secondary findings from clinical genomic sequencing: Prevalence, patient perspectives, family history assessment, and healthcare costs from a multi-site study, 2018-10-05

• Brain pathologies in extreme old age, 2015-10-19

• An international policy on returning genomic research results, 2021-07-15

• Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study, 2017-05-16

• Research Results: Preserving Newborn Blood Samples, 2012-11-07

• Parents' Preferences for Return of Results in Pediatric Genomic Research, 2014-03-13

• How could disclosing incidental information from whole-genome sequencing affect patient behavior?, 2013-11-25

• Navigating the Research-Clinical Interface in Genomic Medicine: Analysis from the CSER Consortium, 2017-08-31

• Summarizing polygenic risks for complex diseases in a clinical whole genome report, 2014-10-23

• Short Term Costs of Integrating Whole Genome Sequencing into Primary Care and Cardiology Settings: A Pilot Randomized Trial, 2018-03-22

• Reducing false positive incidental findings with ensemble genotyping and logistic regression-based variant filtering methods, 2014-06-24

• The Beliefs, Motivations, and Expectations of Parents Who Have Enrolled Their Children in a Genetic Biorepository, 2012-01-26

• Prioritizing disease-linked variants, genes, and pathways with an interactive whole genome analysis pipeline, 2014-03-06

• Common genetic variants in theCLDN2andPRSS1-PRSS2loci alter risk for alcohol-related and sporadic pancreatitis, 2012-11-11

• Reclassification of genetic-based risk predictions as GWAS data accumulate, 2016-02-17

• Participant satisfaction with a preference-setting tool for the return of individual research results in pediatric genomic research, 2019-07-17

• Exploring Concordance and Discordance for Return of Incidental Findings from Clinical Sequencing, 2012-03-15

• Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium, 2016-03-25

• Profiles of Cognitive Functioning in a Population-Based Sample of Centenarians Using Factor Mixture Analysis, 2013-01-15

• Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease, 2021-09-28

• The genetic architecture of the human cerebral cortex, 2020-03-20

• How behavioral economics can help to avoid ‘The last mile problem' in whole genome sequencing, 2015-01-22

• A curated gene list for reporting results of newborn genomic sequencing, 2017-01-12

• Explaining, not just predicting, drives interest in personal genomics, 2015-08-01

• The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine, 2014-03-20

• The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI), 2013-04-01

• Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease, 2016-04-11

• Aggregate penetrance of genomic variants for actionable disorders in European and African Americans, 2016-11-09

• Association analysis of rare variants near theAPOEregion with CSF and neuroimaging biomarkers of Alzheimer's disease, 2017-05-24

• Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights, 2021-03-25

• Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues, 2021-01-28

• Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing, 2012-01-12

• Factors Affecting Recall of Different Types of Personal Genetic Information about Alzheimer's Disease Risk: The REVEAL Study, 2015-01-24

• Automated Typing of Red Blood Cell and Platelet Antigens from Whole Genome Sequencing, 2018-05-17

• Enhancing Autonomy in Biobank Decisions: Too Much of a Good Thing?, 2018-02-23

• Parental Interest in Genomic Sequencing of Newborns: Enrollment Experience from the BabySeq Project, 2018-09-13

• Using Alzheimer's disease as a model for genetic risk disclosure: Implications for personal genomics, 2011-07-18

• Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network, 2020-04-27

• Genetic Analysis of Quantitative Phenotypes in AD and MCI: Imaging, Cognition and Biomarkers, 2014-01-28

• Ethics and Genomic Incidental Findings, 2013-05-16

• Differences Between African American and White Research Volunteers in Their Attitudes, Beliefs and Knowledge Regarding Genetic Testing for Alzheimer's Disease, 2011-06-09

• Characterizing Genetic Variants for Clinical Action, 2014-03-13

• Awareness and utilization of genetic testing among Hispanic and Latino adults living in the US: The Hispanic Community Health Study/Study of Latinos, 2022-11-19

• Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: A randomized controlled trial, 2018-12-10

• Family Health History Reporting is Sensitive to Small Changes in Wording, 2016-05-05

• Clinical utility of genomic sequencing: a measurement toolkit, 2020-12-15

• Assessing the Costs and Cost-Effectiveness of Genomic Sequencing, 2015-12-10

• Effects of General Medical Health on Alzheimer Progression: the Cache County Dementia Progression Study, 2012-06-12

• Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization, 2022-10-07

• Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Impaired Patients and Visit Companions: Findings from The REVEAL Study, 2016-12-14

• Novel genetic loci underlying human intracranial volume identified through genome-wide association, 2016-10-03

• Effects of Participation in a U.S. Trial of Newborn Genomic Sequencing on Parents at Risk for Depression, 2021-07-26

• ‘Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project, 2015-01-10

• Genome-wide association study of rate of cognitive decline in Alzheimer's Disease patients identifies novel genes and pathways, 2020-06-23

• How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study, 2015-06-16

• The BabySeq project: implementing genomic sequencing in newborns, 2018-07-09

• Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience, 2018-08-21

• Age-at-Onset in Late Onset Alzheimer Disease is Modified by Multiple Genetic Loci, 2015-01-13

• Quantifying Downstream Health Care Utilization in Studies of Genomic Testing, 2020-03-20

• Are Physicians Prepared for Whole Genome Sequencing? A Qualitative Analysis, 2015-07-07

• Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4, 2022-10-09

• The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study, 2015-10-15

• Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study, 2013-07-05

• Distinct Communication Patterns During Genetic Counseling for Late-Onset Alzheimer's Risk Assessment, 2013-11-05

• Reconciling Opportunistic and Population Screening in Clinical Genomics, 2019-01-09

• Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol A Randomized Clinical Trial Effect of Genetic Testing for Statin Myopathy Risk vs Usual Care on Cholesterol, 2020-12-03

• A systematic approach to the reporting of medically relevant findings from whole genome sequencing, 2014-12-14

• Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium, 2019-02-27

• GA4GH: International policies and standards for data sharing across genomic research and healthcare, 2021-11-10

• Development of a clinical polygenic risk score assay and reporting workflow, 2022-04-18

• Variants inPPP3R1andMAPTare associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study, 2013-05-30

• Do research participants share genomic screening results with family members?, 2021-10-19

• Associations between self-referral and health behavior responses to genetic risk information, 2015-01-31

• FASTKD2is associated with memory and hippocampal structure in older adults, 2014-11-11

• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception, 2013-08-07

• Genetic Studies of Quantitative MCI and AD Phenotypes in ADNI: Progress, Opportunities, and Plans, 2015-05-19

• Workforce Considerations When Building a Precision Medicine Program, 2022-11-19

• Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project, 2016-01-08

• Effectiveness of a web-based personalized rheumatoid arthritis risk tool with or without a health educator for knowledge of RA risk factors, 2018-01-10

• Prenatal DNA Sequencing: Clinical, Counseling, and Diagnostic Laboratory Considerations, 2017-04-17

• When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing, 2017-01-27

• The future of direct-to-consumer clinical genetic tests, 2011-06-01

• The impact of whole genome sequencing on the primary care and outcomes of healthy adult patients: A pilot randomized trial, 2017-06-27

• Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project, 2019-03-17

• Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing, 2015-03-26

• Genetic architecture of subcortical brain structures in 38,851 individuals, 2019-10-21

• Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers, 2014-12-03

• Protective Variant for Hippocampal Atrophy Identified by Whole Exome Sequencing, 2015-02-14

• Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: Rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives, 2014-08-20

• How to know when physicians are ready for genomic medicine, 2015-05-13

• The Alzheimer's Disease Neuroimaging Initiative 3: continued innovation for clinical trial improvement, 2016-12-05

• Cost Analyses of Genomic Sequencing - Lessons Learned from the MedSeq Project, 2018-08-14